Martin Schulz (M Schulz)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 32

Top Venues

Clinical pharmacokinetics

European journal of clinical pharmacology

Antibiotics (Basel, Switzerland)

Pharmacy practice

ABDA - Bundesvereinigung Deutscher Apothekerverbände

University of Hamburg (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

ABDA - Bundesvereinigung Deutscher Apothekerverbände

Germany

Director :: Medicine

Education History

University of Hamburg

Germany

PHD

Publications

Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics 63 (4) (2024)
Isabelle Arnet, Christiane Eickhoff, Laura J Sahm, Sabine Caloz, Michael Mittag, Martin Schulz, Allemann Samuel
Inconclusiveness of psychometric testing of medication adherence questionnaires. European journal of clinical pharmacology 80 (8) (2024)
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics 63 (4) (2024)
Isabelle Arnet, Christiane Eickhoff, Laura J Sahm, Sabine Caloz, Michael Mittag, Martin Schulz, Allemann Samuel
Inconclusiveness of psychometric testing of medication adherence questionnaires. European journal of clinical pharmacology 80 (8) (2024)
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics 63 (4) (2024)
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics 63 (4) (2024)
Isabelle Arnet, Christiane Eickhoff, Laura J Sahm, Sabine Caloz, Michael Mittag, Martin Schulz, Allemann Samuel
Inconclusiveness of psychometric testing of medication adherence questionnaires. European journal of clinical pharmacology (2024)
Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster, Juergen Burhenne, Martin Schulz, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. Clinical pharmacokinetics (2024)
Isabelle Arnet, Christiane Eickhoff, Laura J Sahm, Sabine Caloz, Michael Mittag, Martin Schulz, Allemann Samuel
Inconclusiveness of psychometric testing of medication adherence questionnaires. European journal of clinical pharmacology 80 (8) (2024)
Christiane Eickhoff, Uta Müeller, Sophie Thomas, Christian Schmidt, Lisa Sophie Hartling, Sebastian Michael, Martin Schulz, Thilo Bertsche
Patients' Use of a Standardized Medication List - A Mixed Methods Study. Patient preference and adherence 17 (2023)
Martin Schulz, Ulrich Laufs
Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy. Clinical research in cardiology : official journal of the German Cardiac Society (2023)
Michael Kunz, Felix Götzinger, Cathy M Jacobs, Lucas Lauder, Christian Ukena, Markus R Meyer, Ulrich Laufs, Martin Schulz, Michael Böhm, Felix Mahfoud
Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study. BMJ open 13 (11) (2023)
Martin Schulz, Nina Griese-Mammen, Uta Müeller
Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain. International journal of clinical pharmacy (2022)
Gabriele Gradl, Marita Kieble, Jens Nagaba, Martin Schulz
Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Felix Mahfoud, Marita Kieble, Salka Enners, Ulrich Laufs, Ulrich Laufs, Michael Böhm, Martin Schulz
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia. Clinical research in cardiology : official journal of the German Cardiac Society (2022)
Gabriele Gradl, Marita Kieble, Jens Nagaba, Martin Schulz
Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Gabriele Gradl, Johanna Werning, Salka Enners, Marita Kieble, Martin Schulz
Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014-2019. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Christiane Eickhoff, Nina Griese-Mammen, Uta Müeller, André Said, Martin Schulz
Primary healthcare policy and vision for community pharmacy and pharmacists in Germany. Pharmacy practice 19 (1) (2021)
Salka Enners, Gabriele Gradl, Marita Kieble, Michael Böhm, Ulrich Laufs, Martin Schulz
Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave. Pharmacoepidemiology and drug safety 30 (11) (2021)
Pia M Schumacher, Nicolas Becker, Ross T Tsuyuki, Nina Griese-Mammen, Sheri L Koshman, Michael A McDonald, M Marcel Bouvy, Frans H Rutten, Ulrich Laufs, Michael Böhm, Martin Schulz
The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta-analysis. ESC heart failure 8 (5) (2021)
Ulrike Maria Rudolph, Salka Enners, Marita Kieble, Felix Mahfoud, Michael Böhm, Ulrich Laufs, Martin Schulz
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany. Journal of human hypertension 35 (10) (2020)
Martin Schulz, Nina Griese-Mammen, Pia M Schumacher, Stefan D Anker, Friedrich Koehler, Christian Ruckes, Volker Rettig-Ewen, Rolf Wachter, Dietmar Trenk, Michael Böhm, Ulrich Laufs
The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial. ESC heart failure (2020)
Evelien Moorkens, Teresa Barcina Lacosta, Arnold G Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert W Selke, Isabelle Huys, Steven R A Simoens
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany. Pharmaceuticals (Basel, Switzerland) 13 (10) (2020)
Martin Schulz, Nina Griese-Mammen, Pia M Schumacher, Dorothea Strauch, Leonard Freudewald, André Said, Ross T Tsuyuki, Ulrich Laufs, Ulrich Kintscher, Michael Böhm, Felix Mahfoud
Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. Journal of clinical hypertension (Greenwich, Conn.) 22 (10) (2020)
Martin Schulz, Achim Schmoldt, Hilke Andresen-Streichert, Stefanie Iwersen-Bergmann
Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Critical care (London, England) 24 (1) (2020)
G A Hofmann, Gabriele Gradl, Martin Schulz, G Haidinger, A Tanew, Benedikt Weber
The frequency of photosensitizing drug dispensings in Austria and Germany: a correlation with their photosensitizing potential based on published literature. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (3) (2019)
Martin Schulz, Nina Griese-Mammen, Michael Böhm, Ulrich Laufs
Letter on 'Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial': reply. European journal of heart failure 22 (3) (2019)
André Said, Matthias Ganso, Leonard Freudewald, Martin Schulz
Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists. International journal of clinical pharmacy 41 (6) (2019)
Martin Schulz, Nina Griese-Mammen, Stefan D Anker, Friedrich Koehler, Peter Ihle, Christian Ruckes, Pia M Schumacher, Dietmar Trenk, Michael Böhm, Ulrich Laufs, null null
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. European journal of heart failure 21 (8) (2019)
Gabriele Gradl, Martina Teichert, Marita Kieble, Johanna Werning, Martin Schulz
Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016. Pharmacoepidemiology and drug safety 27 (12) (2018)
Gabriele Gradl, Eva-Maria Krieg, Martin Schulz
Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons. Pharmacy practice 14 (3) (2016)
Martin Schulz, Ralf Goebel, Claudia Schumann, Petra Zagermann-Muncke
Non-prescription dispensing of emergency oral contraceptives: Recommendations from the German Federal Chamber of Pharmacists [Bundesapothekerkammer]. Pharmacy practice 14 (3) (2016)

Martin Schulz.css-eqlu8i{font-size:small;padding-left:4px;} (M Schulz)

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Schulz (M Schulz)